Globe Life Inc. (NYSE:GL) Receives $174.11 Consensus Price Target from Analysts

Globe Life Inc. (NYSE:GL) has been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have covered the stock in the last year is $174.1111.

A number of equities research analysts have recently issued reports on GL shares. Truist Financial boosted their target price on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 24th. Keefe, Bruyette & Woods reissued a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a research report on Thursday, March 26th. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. Morgan Stanley boosted their target price on shares of Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, May 21st. Finally, Piper Sandler boosted their target price on shares of Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, May 26th.

Globe Life Trading Up 1.0%

GL stock opened at $166.75 on Tuesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07. The company has a fifty day moving average price of $152.88 and a two-hundred day moving average price of $144.52. Globe Life has a one year low of $116.73 and a one year high of $168.27. The stock has a market cap of $12.95 billion, a price-to-earnings ratio of 11.53 and a beta of 0.49.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period last year, the firm earned $3.07 earnings per share. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Equities analysts anticipate that Globe Life will post 15.64 EPS for the current year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s payout ratio is presently 9.13%.

Insider Buying and Selling at Globe Life

In other news, CEO James Matthew Darden sold 4,663 shares of the business’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the sale, the chief executive officer owned 58,451 shares of the company’s stock, valued at approximately $8,994,439.88. The trade was a 7.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Frank M. Svoboda sold 20,000 shares of the business’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. The trade was a 27.02% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 105,929 shares of company stock worth $16,382,450. Insiders own 2.11% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Compound Planning Inc. raised its stake in Globe Life by 4.3% in the fourth quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after purchasing an additional 82 shares in the last quarter. Root Financial Partners LLC raised its stake in Globe Life by 23.3% in the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after purchasing an additional 83 shares in the last quarter. Transcend Capital Advisors LLC raised its stake in Globe Life by 3.9% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after purchasing an additional 84 shares in the last quarter. Natural Investments LLC raised its stake in Globe Life by 2.6% in the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after purchasing an additional 87 shares in the last quarter. Finally, Parallel Advisors LLC raised its stake in Globe Life by 5.6% in the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock valued at $231,000 after purchasing an additional 87 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.